HypoKPP
Hypokalemic Periodic Paralysis (HypoKPP) is a rare, inherited channelopathy characterized by episodes of muscle weakness or paralysis associated with a decrease in the potassium levels in the blood. This condition is a primary form of Periodic Paralysis, a group of disorders that lead to occasional episodes of muscle weakness or paralysis.
Causes and Genetics[edit | edit source]
HypoKPP is primarily caused by mutations in the CACNA1S or SCN4A genes. These genes encode for the alpha subunit of the skeletal muscle voltage-gated calcium channel and the alpha subunit of the skeletal muscle voltage-gated sodium channel, respectively. Mutations in these genes disrupt the normal function of these channels, leading to the characteristic episodes of muscle weakness or paralysis in individuals with HypoKPP.
Symptoms[edit | edit source]
The hallmark of HypoKPP is the episodic muscle weakness or paralysis, which can vary in severity from mild weakness to complete paralysis. These episodes often begin in adolescence and are triggered by factors such as rest after exercise, high carbohydrate meals, stress, and exposure to cold temperatures. The muscle weakness typically affects the arms and legs but can also involve muscles used for breathing and eye movements. During an episode, reflexes may be diminished or absent, but sensation remains intact.
Diagnosis[edit | edit source]
Diagnosis of HypoKPP involves a combination of clinical evaluation, family history, laboratory tests showing hypokalemia (low potassium levels) during episodes, and genetic testing to identify mutations in the CACNA1S or SCN4A genes. Electromyography (EMG) and muscle biopsy may also be used to support the diagnosis.
Treatment[edit | edit source]
Treatment of HypoKPP focuses on preventing episodes of muscle weakness and treating acute episodes when they occur. Preventive measures may include dietary changes such as low carbohydrate and high potassium diets, and medications like potassium supplements, diuretics (to increase potassium levels), and carbonic anhydrase inhibitors. During an acute episode, oral or intravenous potassium may be administered to help restore muscle strength.
Prognosis[edit | edit source]
The prognosis for individuals with HypoKPP is generally good, especially with early diagnosis and appropriate management of the condition. Most individuals can lead normal lives, although some may experience persistent muscle weakness or other complications over time.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD